See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Par Pacific Holdings, Inc. (PARR) - free report >>
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Par Pacific Holdings, Inc. (PARR) - free report >>
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for Oct. 23
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 23:
Par Pacific Holdings, Inc. (PARR - Free Report) : This energy and infrastructure business has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100.6% over the last 60 days.
Par Pacific Holdings, Inc. Price and Consensus
Par Pacific Holdings, Inc. price-consensus-chart | Par Pacific Holdings, Inc. Quote
Par Pacific’s shares gained 17.5% over the last three months compared with the S&P 500’s advance of 6%. The company possesses a Momentum Score of A.
Par Pacific Holdings, Inc. Price
Par Pacific Holdings, Inc. price | Par Pacific Holdings, Inc. Quote
Chemomab Therapeutics Ltd. (CMMB - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 70% over the last 60 days.
Chemomab Therapeutics Ltd. Sponsored ADR Price and Consensus
Chemomab Therapeutics Ltd. Sponsored ADR price-consensus-chart | Chemomab Therapeutics Ltd. Sponsored ADR Quote
Chemomab’s shares gained 18.9% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of A.
Chemomab Therapeutics Ltd. Sponsored ADR Price
Chemomab Therapeutics Ltd. Sponsored ADR price | Chemomab Therapeutics Ltd. Sponsored ADR Quote
Guess?, Inc. : This apparel and accessories company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Guess?, Inc. Price and Consensus
Guess?, Inc. price-consensus-chart | Guess?, Inc. Quote
Guess’ shares gained 27.4% over the last three months compared with the S&P 500’s advance of 6%. The company possesses a Momentum Score of B.
Guess?, Inc. Price
Guess?, Inc. price | Guess?, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.